文献速递腹部泌尿生殖介入CTMR

肾脏消融术后影像随访:复发性肿瘤能教会我们什么

Imaging following renal ablation: what can we learn from recurrent tumors?
PubMed 文献 · Abdom Radiol (NY) · 2018-01-01

研究回顾2002至2015年913例患者共988次肾脏消融、1064个肿瘤,24例(2.6%)出现局部肿瘤进展,中位影像随访30个月;23例经对比增强CT和/或MRI评估,局部进展中位出现于消融后11个月,16/23(70%)行皮髓质期成像,全部病例均在皮髓质期被识别,15/16(94%)在皮髓质期最明显,无病例在平扫或排泄期最佳显示。

要点

  • 肾脏消融后局部肿瘤进展可延迟出现,中位消融后11个月(范围1至68个月)。
  • 皮髓质期成像在全部23例中均可识别局部进展,94%(15/16)在该期最明显。
  • 无病例在平扫或排泄期最佳显示局部进展,排泄期对诊断局部进展并非必需。

核心结论

  • 肾脏消融后延迟复发是可能的,因此对消融患者应延长随访。
  • 几乎所有局部肿瘤进展病例均在皮髓质期成像最明显,该期应纳入任何消融后影像方案。
  • 任何病例均不需要排泄期图像来诊断局部肿瘤进展,排泄期可 excluded from routine post-ablation follow-up。

研究设计与样本

  • 回顾性研究,2002至2015年913例患者接受988次肾脏消融,治疗1064个肿瘤。
  • 局部肿瘤进展见于24例(2.6%)患者,中位影像随访30个月(范围0至139个月)。
  • 1例局部进展患者仅行平扫MRI随访,被排除评估;其余23例由3名体部放射科医生审阅对比增强CT和/或MRI随访影像。

关键影像表现/征象

  • 局部肿瘤进展在消融后中位11个月(范围1至68个月)经对比增强CT或MRI识别。
  • 16/23(70%)患者行皮髓质期成像,全部病例在该期识别局部进展。
  • 15/16(94%)患者局部进展在皮髓质期较任何其他期相最明显。
  • 无病例局部进展在平扫或排泄期图像上最佳显示。

临床应用与阅片要点

  • 消融后随访方案应包含皮髓质期对比增强成像。
  • 排泄期图像对诊断局部肿瘤进展并非必需,可 excluded from routine post-ablation follow-up。
  • 消融后延迟复发可能,随访应延长。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The purpose of the study was to evaluate the post-contrast appearance of local tumor progression (LTP) following renal ablation to better understand patterns of tumor recurrence and to optimize follow-up imaging protocols.

METHODS: From 2002 to 2015, 913 patients underwent 988 renal ablation procedures for treatment of 1064 tumors. LTP was identified in 24 (2.6%) patients during median imaging follow-up of 30 months (range 0-139). One patient with LTP was followed with non-contrast MRI only and was excluded from evaluation. Three body radiologists reviewed the contrast-enhanced CT and/or MRI follow-up imaging in the remaining 23 patients to determine the timing and imaging appearance of the recurrent tumor.

RESULTS: Local tumor progression was identified on contrast-enhanced CT or MRI at median 11 months (range 1 and 68) after renal ablation. Corticomedullary phase imaging was performed in 16/23 (70%) patients. LTP was identified on the corticomedullary phase in all cases, and was most conspicuous on the corticomedullary phase compared to any other phase of imaging in 15/16 (94%) patients. No cases of LTP were best visualized on non-contrast or excretory phase images.

CONCLUSIONS: Delayed recurrence following renal ablation is possible; therefore, extended follow-up is indicated in ablation patients. Almost all cases of LTP were best visualized on the corticomedullary phase of imaging, which should be included in any post-ablation imaging protocol. Excretory phase images were not required to diagnose LTP in any case and could be excluded from routine post-ablation follow-up.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Eiken PW, Atwell TD, Kurup AN, et al. Imaging following renal ablation: what can we learn from recurrent tumors? Abdom Radiol (NY). 2018. PMID: 29525875. doi:10.1007/s00261-018-1541-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。